These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 183703)

  • 61. Tumor producing capacity of temperature sensitive mutants of avian sarcoma viruses in chicks.
    Toyoshima K; Owada M; Kozai Y
    Biken J; 1973 Sep; 16(3):103-10. PubMed ID: 4357954
    [No Abstract]   [Full Text] [Related]  

  • 62. Induction of tumors in the liver of hamsters by an avian adenovirus (CELO).
    Stenback WA; Anderson JP; McComick KJ; Trentin JJ
    J Natl Cancer Inst; 1973 Apr; 50(4):963-70. PubMed ID: 4350030
    [No Abstract]   [Full Text] [Related]  

  • 63. Sarcomas in the wistar rat.
    Lum GS; Schreiner AW
    Oncology; 1967; 21(2):117-28. PubMed ID: 5587630
    [No Abstract]   [Full Text] [Related]  

  • 64. Pseudotypes of feline sarcoma virus contain an 85,000-dalton protein with feline oncornavirus-associated cell membrane antigen (FOCMA) activity.
    Sherr CJ; Sen A; Todaro GJ; Sliski A; Essex M
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1505-9. PubMed ID: 206902
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cyclic-3', 5'-AMP-dependent and independent protein kinase levels in normal and feline sarcoma virus transformed cells.
    Troy FA; Vijay IK; Kawakami TG
    Biochem Biophys Res Commun; 1973 May; 52(1):150-8. PubMed ID: 4351301
    [No Abstract]   [Full Text] [Related]  

  • 66. Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody.
    Grant CK; Harris D; Essex ME; Pickard DK; Hardy WD; de Noronha F
    J Natl Cancer Inst; 1980 Jun; 64(6):1527-33. PubMed ID: 6246303
    [No Abstract]   [Full Text] [Related]  

  • 67. Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma.
    McCarty JM; Grant CK
    Cell Immunol; 1983 Oct; 81(1):157-68. PubMed ID: 6311439
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sarcoma virus-induced transformation specific antigen: presence of antibodies in cats that were naturally exposed to leukemia virus.
    Sliski AH; Essex M
    Virology; 1979 Jun; 95(2):581-6. PubMed ID: 88797
    [No Abstract]   [Full Text] [Related]  

  • 69. Transformation and productive infection of human osteosarcoma cells by a feline sarcoma virus.
    McAllister RM; Filbert JE; Nicolson MO; Rongey RW; Gardner MB; Gilden RV; Huebner RJ
    Nat New Biol; 1971 Apr; 230(17):279-82. PubMed ID: 4325140
    [No Abstract]   [Full Text] [Related]  

  • 70. Towards a biochemical description of malignant transformation. Identification and functional characterization of the Rous sarcoma virus transforming gene product.
    Erikson RL
    Cancer; 1984 May; 53(10):2041-5. PubMed ID: 6322956
    [No Abstract]   [Full Text] [Related]  

  • 71. Syncytial giant cell focus assay for viruses derived from feline leukemia and a simian sarcoma.
    Rangan SR; Ueberhorst PJ; Wong MC
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1077-82. PubMed ID: 4348580
    [No Abstract]   [Full Text] [Related]  

  • 72. Immunization of Rous sarcoma virus-inoculated marmosets with BCG and transformed allogeneic cells.
    Schauf V; Massey R; Deinhardt F; Kruse R
    J Natl Cancer Inst; 1975 Jan; 54(1):151-5. PubMed ID: 163312
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oncogenic RNA viruses.
    Allen DW; Cole P
    CA Cancer J Clin; 1973; 23(3):193-200. PubMed ID: 4122296
    [No Abstract]   [Full Text] [Related]  

  • 74. Preparation of cell-free feline oncornavirus-associated cell membrane antigen.
    Wolff LH; Olsen RG; Hoover EA; Yohn DS; Schaller JP
    J Natl Cancer Inst; 1977 Mar; 58(3):791-3. PubMed ID: 190418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors.
    Gorczynski RM; Knight RA
    Eur J Immunol; 1975 Feb; 5(2):148-55. PubMed ID: 1086221
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transformation of horse skin cells by type-C sarcoma viruses.
    Rhim JS; Ro HS; Kim EB; Gilden RV; Huebner RJ
    Int J Cancer; 1975 Feb; 15(2):171-9. PubMed ID: 165152
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Defectiveness of a feline sarcoma virus demonstrable by the acquisition of a new envelope antigenic type by phenotypic mixing.
    Garma PS; Log T
    Virology; 1977 May; 78(1):336-9. PubMed ID: 193272
    [No Abstract]   [Full Text] [Related]  

  • 78. Feline leukemia virus-and feline sarcoma virus-related polypeptides released by virus producer and nonproducer cells.
    Ganguly K; Essex M
    Cancer Invest; 1985; 3(6):523-34. PubMed ID: 3002564
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The effect of immunization on sarcoma A-12 growth in hamsters].
    Ageenko AI; Timofeev VT; Bashkaev IS; Vardosanidze ESh
    Vopr Onkol; 1970; 16(10):64-6. PubMed ID: 5516744
    [No Abstract]   [Full Text] [Related]  

  • 80. Biological, immunological, and molecular properties of revertants of cat cells transformed by murine sarcoma virus.
    Fischinger PJ; Blevins CS; Frankel AE; Tuttle-Fuller N; Haapala DK; Nomura S; Robey WG
    Cancer Res; 1981 Mar; 41(3):958-65. PubMed ID: 6257388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.